These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18950780)

  • 1. Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease.
    Bartolini M; Greig NH; Yu QS; Andrisano V
    J Chromatogr A; 2009 Mar; 1216(13):2730-8. PubMed ID: 18950780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor.
    Bartolini M; Cavrini V; Andrisano V
    J Chromatogr A; 2007 Mar; 1144(1):102-10. PubMed ID: 17134713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monolithic micro-immobilized-enzyme reactor with human recombinant acetylcholinesterase for on-line inhibition studies.
    Bartolini M; Cavrini V; Andrisano V
    J Chromatogr A; 2004 Mar; 1031(1-2):27-34. PubMed ID: 15058565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of human serum butyrylcholinesterase inhibition by a novel experimental Alzheimer therapeutic, dihydrobenzodioxepine cymserine.
    Kamal MA; Klein P; Luo W; Li Y; Holloway HW; Tweedie D; Greig NH
    Neurochem Res; 2008 May; 33(5):745-53. PubMed ID: 17985237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.
    Darvesh S; McDonald RS; Darvesh KV; Mataija D; Conrad S; Gomez G; Walsh R; Martin E
    Bioorg Med Chem; 2007 Oct; 15(19):6367-78. PubMed ID: 17681768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
    Kamal MA; Al-Jafari AA; Yu QS; Greig NH
    Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in-vivo active reversible butyrylcholinesterase inhibitor.
    Košak U; Brus B; Knez D; Šink R; Žakelj S; Trontelj J; Pišlar A; Šlenc J; Gobec M; Živin M; Tratnjek L; Perše M; Sałat K; Podkowa A; Filipek B; Nachon F; Brazzolotto X; Więckowska A; Malawska B; Stojan J; Raščan IM; Kos J; Coquelle N; Colletier JP; Gobec S
    Sci Rep; 2016 Dec; 6():39495. PubMed ID: 28000737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved immobilized enzyme reactor-mass spectrometry-based label free assay for butyrylcholinesterase ligand screening.
    Vilela AFL; Seidl C; Lima JM; Cardoso CL
    Anal Biochem; 2018 May; 549():53-57. PubMed ID: 29550345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On-line chromatographic screening of matrix metalloproteinase inhibitors using immobilized MMP-9 enzyme reactor.
    Ma X; Chan EC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1777-83. PubMed ID: 20537964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alkaloids of Amaryllidaceae as Inhibitors of Cholinesterases (AChEs and BChEs): An Integrated Bioguided Study.
    Cortes N; Sierra K; Alzate F; Osorio EH; Osorio E
    Phytochem Anal; 2018 Mar; 29(2):217-227. PubMed ID: 29044771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Li Q; Yang H; Chen Y; Sun H
    Eur J Med Chem; 2017 May; 132():294-309. PubMed ID: 28371641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
    Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
    Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
    Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.
    Bono GF; Simão-Silva DP; Batistela MS; Josviak ND; Dias PF; Nascimento GA; Souza RL; Piovezan MR; Souza RK; Furtado-Alle L
    Neurochem Int; 2015 Feb; 81():57-62. PubMed ID: 25624079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silica-immobilized enzyme reactors; application to cholinesterase-inhibition studies.
    Luckarift HR; Johnson GR; Spain JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):310-6. PubMed ID: 16884963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catalytic properties of cholinesterases immobilized in a gelatin membrane].
    Kuznetsova LP; Kugusheva LI; Nikol'skaia EB
    Ukr Biokhim Zh (1978); 1990; 62(6):42-8. PubMed ID: 2087792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the interaction of main potato glycoalkaloids in inhibition of immobilized butyryl cholinesterase].
    Arkhypova VM; Dziadevych SV; Jaffrezic-Renault N; Martelet C; Soldatkin OP
    Ukr Biokhim Zh (1999); 2006; 78(5):155-61. PubMed ID: 17290795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.